肺癌循环肿瘤源性生物标志物
摘要
美国国立卫生研究院生物标志物定义工作组将生物标志物定义为“一种具有能客观测量同时可用于评价一般生物过程、发病过程或医疗干预相关药物反应的指示物”[1]。大量正在进行的肺癌相关研究致力于探讨用于早期诊断和高风险预测的气道上皮细胞、痰液、呼气、尿液和血液中的生物标志物。在此，着重评述肺癌的循环生物标志物，尤其是循环肿瘤细胞（circulating tumor cells，CTCs）与循环核酸（circulating nucleic acids，CNAs）。
出处
《国际病理科学与临床杂志》
CAS
2013年第6期476-477,共2页
Journal of International Pathology and Clinical Medicine
参考文献15
-
1Mok TS. Personalized medicine in lung cancer:what we need to know[J].Nat Rev Clin Oncol,2011,(11):661-668.
-
2Riethdorf S,Wikman H,Pantel K. Review:Biological relevance of disseminated tumor cells in cancer patients[J].{H}International Journal of Cancer,2008,(09):1991-2006.
-
3pantel K,Brakenhoff RH,Brandt B. Detection,clinical relevance and specific biological properties of disseminating tumour cells[J].{H}Nature Reviews Cancer,2008,(05):329-340.
-
4O'FlahertyJD,Gray S,Richard D. Circulating tumour cells,their role in metastasis and their clinical utility in lung cancer[J].{H}Lung Cancer,2012,(01):19-25.
-
5Krebs MG,Sloane R,Priest L. Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer[J].{H}Journal of Clinical Oncology,2011,(12):1556-1563.
-
6Tanaka F,Yoneda K,Kondo N. Circulating tumor cell as a diagnostic marker in primary lung cancer[J].{H}Clinical Cancer Research,2009,(22):6980-6986.
-
7Hou JM,Krebs MG,Lancashire L. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer[J].{H}Journal of Clinical Oncology,2012,(05):525-532.
-
8Naito T,Tanaka F,Ono A. Prognostic impact of circulating tumor cells in patients with small cell lung cancer[J].{H}JOURNAL OF THORACIC ONCOLOGY,2012,(03):512-519.
-
9Krebs MG,Hou JM,Sloane R. Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial markerdependent and-independent approaches[J].J Thorac O ncol,2012,(02):306-315.
-
10Lecharpentier A,Vielh P,Perez-Moreno P. Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer[J].{H}British Journal of Cancer,2011,(09):1338-1341.
-
1曾仁凤,何振华,张秀峰.上皮细胞间质转化与肺纤维化的研究进展[J].当代医学,2014,20(2):12-13. 被引量：9
-
2高永良.卵巢癌的化疗[J].浙江肿瘤通讯,1991(2):79-82.
-
3孙祥宙,丘少鹏,邓春华,戴宇平,郑克立,徐战平.吡喃阿霉素膀胱内灌注预防膀胱癌术后复发的临床研究[J].国外医学（泌尿系统分册）,2004,24(3):430-432.
-
4杨荣辰,包国荣,武艳华,杨继旭,刘剑昌,韩明辉,司晓东.沙培林膀胱内灌注预防膀胱癌术后复发的临床研究[J].中原医刊,2008,35(7):51-52. 被引量：1
-
5曲泽睿,张侠.非小细胞肺癌原发灶与转移灶间的EGFR基因差异性研究进展[J].医学综述,2013,19(20):3700-3702.
-
6潘莉萍.抗癌药物静脉给药的观察及护理[J].广西中医学院学报,2000,17(3):134-135.
-
7Heather Lindsey.环境因素与癌症[J].抗癌,2006(1):42-43.
-
8蒋奕玫,赵任.直肠癌术前放疗研究进展[J].中华胃肠外科杂志,2011,14(5):391-394. 被引量：4
-
9景蓉蓉,王惠民,王志伟,张鲁榕,鞠少卿.血循环核酸作为肿瘤诊断生物标志物的研究进展[J].中华肿瘤杂志,2011,33(12):881-884.
-
10梁振强,梁世雄.胰腺癌的三维适形放疗[J].中国医学文摘（肿瘤学）,2005,19(4):335-336.
